About MSP Medicines LLP
Data last updated:
MSP Medicines LLP is a limited liability partnership (LLP) based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 19 June 2015 and has been in existence for over 11 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAE-2082. Its GSTIN is 27AABFZ4538M1ZM (Maharashtra).
The LLP has a total obligation of contribution of ₹11.36 Lakh. It is led by designated partners Sunil Haripant Pophale and Paras Vinod Gandhi.
Its latest statement of accounts is for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹27.9 Cr. For the same year it recorded a net profit of ₹4.89 Cr (net margin 17.5%) and EBITDA of ₹10.38 Cr (EBITDA margin 37.2%). Revenue has grown at a compounded annual rate (CAGR) of 51% over three years and 83% over five years.
The LLP has about 98 employees on its provident fund (EPFO) records.
The LLP is associated with 1 brand: Zenvision Pharma. As per MCA filings, the LLP has open charges of ₹32.98 Cr and satisfied charges of ₹1.9 Cr on record. Court records list 7 cases involving the LLP, including 1 filed by the LLP and 6 filed against it; 4 cases are pending.
For more details, the LLP can be reached via its website zenvisionpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address1st Floor Plot No.4 K Chambers Purushottamdas Thakurdas Road Siddharth College Fort M, Umbai, Mumbai, Maharashtra, India – 400001
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of MSP Medicines LLP FY 2024 filings available
MSP Medicines LLP reported revenue of ₹27.9 Cr for FY 2023.
Compounded Annual Growth Rate (CAGR) of MSP Medicines LLP
Revenue has grown at a compounded annual rate (CAGR) of 83% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of MSP Medicines LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | ₹4.89 Cr | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of MSP Medicines LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 17.5% | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of MSP Medicines are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of MSP Medicines LLP
MSP Medicines LLP is compared with the companies closest to it by revenue in the Pharma industry (Contract Research). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| MSP Medicines LLP this company | •••• | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
| Zieo Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Bangalore, Karnataka, India |
| Li Med Labs Private Limited | •••• | •••• | •••• | •••• | - | Thiruvananthapuram, Kerala, India |
| Olene Life Sciences Private Limited | •••• | •••• | •••• | •••• | - | Chennai, Tamil Nadu, India |
| RXMD Pharmaceutical Physicians Private Limited | •••• | •••• | •••• | •••• | - | Chennai-18., Tamil Nadu, India |
| Sipra Labs Limited | •••• | •••• | •••• | •••• | 66 | Hydrabad, Telangana, India |
| Genei Laboratories Private Limited | •••• | •••• | •••• | •••• | - | Bangalore, Karnataka, India |
| Minal Specialities Private Limited | •••• | •••• | •••• | •••• | - | Daskroi, Gujarat, India |
| KMS Health Center Private Limited | •••• | •••• | •••• | •••• | 13 | Chennai, Tamil Nadu, India |
| Catawba Research (India) Private Limited | •••• | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
| Vanta Bioscience Limited Listed | •••• | •••• | •••• | •••• | 44 | Secunderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below MSP Medicines by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Designated Partners of MSP Medicines LLP
MSP Medicines has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Haripant Pophale | Designated Partner | 19 Jun 2015 | 11 Years 3 Months | Current |
| Paras Vinod Gandhi Also directs: Aarham Speciality Ingredients Private Limited | Partner | 01 Sep 2020 | 6 Years 1 Months | Current |
Ownership and Shareholding of MSP Medicines LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of MSP Medicines LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Nov 2022 | Bank of India | ₹31 Cr | Open |
| 27 Sep 2021 | Canara Bank | ₹1.98 Cr | Open |
| 31 May 2022 | Profectus Capital Private Limited | ₹1.9 Cr | Satisfied |
Total charge records: 3 View all charges
Legal Cases of MSP Medicines LLP
MSP Medicines LLP has 7 court cases on record: 1 filed by MSP Medicines, 6 filed against it. 4 cases are pending and 3 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 6 | 4 |
| High courts | 1 | 0 | 0 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Ecl Finance Limited | Pending |
| District court, Ludhiana, Punjab | Commercial suit | Filed against the company by Hero Fincorp Limited | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Protium Finance Limited | Disposed |
| District court, South, Delhi | Cheque dishonour complaint | Filed against the company by Godrej Finance Limited | Disposed |
| District court, Jaipur Metro II, Rajasthan | Court case (Complaint) | Filed against the company by Clicks Capital Services Private Limited | Pending |
Full case history
All 7 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with MSP Medicines LLP
MSP Medicines operates one associated brand: Zenvision Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides pharmaceutical formulation development and contract manufacturing services globally. | zenvisionpharma.com |
Employees and EPFO Compliance at MSP Medicines LLP
MSP Medicines LLP has a workforce of 98 employees as of Mar 30, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on MSP Medicines LLP
MSP Medicines LLP has 3 designated partner changes on record since 2015: 2 appointments and 1 cessation. The latest: Bobba Venkata Sivakumar ceased to be Designated Partner on 22 Jan 2026.
Credit Ratings, Litigation & Regulatory Alerts for MSP Medicines LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by MSP Medicines LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of MSP Medicines LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of MSP Medicines LLP
MSP Medicines has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABFZ4538M1ZM | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of MSP Medicines LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MSP Medicines LLP
MSP Medicines is an active limited liability partnership based in Mumbai, Maharashtra, India. The LLP works in pharma contract r and d, within the pharma industry. It was incorporated on 19 June 2015 (11+ years old) and is registered under LLPIN AAE-2082.
MSP Medicines reported revenue of ₹27.9 Cr for FY 2023.
MSP Medicines has 2 current designated partners:
- Sunil Haripant Pophale - Designated Partner
- Paras Vinod Gandhi - Partner
MSP Medicines reported a net profit of ₹4.89 Cr (net margin 17.5%) and EBITDA of ₹10.38 Cr (EBITDA margin 37.2%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of MSP Medicines is 51% over three years and 83% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of MSP Medicines is 27AABFZ4538M1ZM, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of MSP Medicines is AAE-2082. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
MSP Medicines has 7 court cases on record: 1 filed by the LLP and 6 filed against it. 4 are pending. Most are in the district courts.
MSP Medicines was incorporated on 19 June 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of MSP Medicines by revenue are Zieo Pharmaceuticals Private Limited, Li Med Labs Private Limited, Olene Life Sciences Private Limited, RXMD Pharmaceutical Physicians Private Limited, Sipra Labs Limited and 5 more, all in the Pharma industry (Contract Research).
Bobba Venkata Sivakumar ceased to be Designated Partner on 22 Jan 2026. Paras Vinod Gandhi was appointed as Partner on 01 Sep 2020. Sunil Haripant Pophale was appointed as Designated Partner on 19 Jun 2015.